CNBC
The Next Phase Of The Obesity Drug Race
The obesity drug market is rapidly evolving beyond Wegovy and Zepbound, with new pills, triple-agonist drugs, and alternative mechanisms entering clinical pipelines. Lilly's experimental Retatrutide showed unprecedented 28% average body weight loss, the highest ever recorded for a drug. Competition is intensifying across weight loss, tolerability, and dosing convenience dimensions.
Big Challenges Ahead For Meta AI Chief Alexandr Wang After A Rocky First Year
One year after Meta's $14 billion acquihire of Scale AI and appointment of Alexandr Wang as chief AI officer, Meta faces scrutiny amid a 19% stock decline. Wang's Meta Superintelligence Labs has shifted away from open source models toward proprietary offerings, with mixed results. Wang now faces pressure to deliver competitive AI models and generate new revenue as Meta's infrastructure spending reaches $145 billion.
Why Retail Investors Are Betting On SpaceX’s Massive IPO
Retail investors are weighing whether to buy into SpaceX's IPO despite an aggressive valuation of nearly $1.8 trillion. While analysts and even some investors acknowledge the valuation is hard to justify on paper, many are still pursuing shares due to Elon Musk's track record, SpaceX's multi-business structure, and fear of missing out. Strategies range from short-term hype trades to long-term bets on the space economy.
SpaceX IPO: Here's What Retail Investors Need To Know
SpaceX is launching its IPO at $135 per share, targeting a $1.75 trillion valuation, with an unusually high 30% of shares allocated to retail investors. Brokerages like Fidelity, Robinhood, and SoFi are participating, though early sellers face restrictions from future IPO access. SpaceX reported a nearly $5 billion net loss in 2025, primarily driven by Elon Musk's X business and AI infrastructure spending.
The SpaceX IPO Could Redefine How Wall Street Values Tech
The video analyzes SpaceX's anticipated IPO and argues it defies traditional Wall Street valuation frameworks. SpaceX combines hypergrowth, strategic national importance, and minimal regulation — a rare trifecta that creates what the presenter calls a 'strategic tech premium.' However, the same indispensability that justifies a premium also invites eventual government control, potentially capping its upside.
Trump Family Earned $500M From Crypto Deal While Investors Took Losses
ALT5 Sigma, a little-known crypto company, raised $750 million from hedge funds and used it to buy crypto tokens from World Liberty Financial, a Trump family-affiliated organization, netting the Trump family approximately $500 million. Since the deal, ALT5 Sigma has faced severe turmoil including leadership changes, auditor replacements, a money laundering conviction in its Canadian subsidiary, and a collapsing stock price. Investors who bought into the deal hoping to share in Trump family business success have instead taken significant losses.
How A ‘Disciplined’ Auto Industry Squeezed Consumers
The U.S. auto industry has deliberately shifted toward selling fewer, more expensive vehicles since the pandemic, generating higher profits while squeezing consumers out of the new car market. Reduced leasing, lower incentives, and constrained production have created a persistent shortage of used vehicles expected to last through 2030. This dynamic has pushed the average new car buyer's household income to $150,000—nearly double the national average.
This Nvidia Challenger Says Its AI Chip Is 10x Faster Than A GPU
d-Matrix, a California-based chip startup, has announced its Corsair AI inference chip is now in full production, claiming it is 10x faster at token generation and 3x cheaper than standalone GPUs. The chip uses on-chip SRAM instead of high-bandwidth memory to bypass the memory bottleneck limiting GPU performance. The company has secured $275 million in funding and partnerships with major players including Microsoft, Arista, Broadcom, and Supermicro.
How Harry's Owner Is Taking On Procter & Gamble
Mammoth Brands, founded by the creators of Harry's razor company, is challenging legacy CPG giants like Procter & Gamble by using a direct-to-consumer first strategy before scaling to retail. The company has grown through acquisitions and new brand launches, including Flamingo, Lume, Mando, and Coterie Diapers. Mammoth's playbook centers on speed, deep customer knowledge, and premium product quality rather than traditional CPG scale.
AI Rollup: Silicon Valley’s New Buyout Playbook Is Hitting Wall Street
Silicon Valley VC firms are executing 'AI rollups' by acquiring Main Street service businesses like HOA managers and accounting firms, then rebuilding them around proprietary AI platforms. The thesis is that AI can break the traditional link between growth and headcount in service businesses, giving them software-like economics. Long Lake, backed by General Catalyst, is the clearest example, having acquired 30+ businesses and built a custom AI platform called Nexus.
Can Trump Negotiate A Better Iran Nuclear Deal Than Obama?
The transcript examines whether Trump can negotiate a better Iran nuclear deal than Obama's 2015 JCPOA, amid an ongoing Iran war. It outlines the history of U.S.-Iran sanctions, the structure and achievements of the original deal, and the significant challenges Trump faces in securing a stronger agreement. Key obstacles include Iran's increased leverage, the absence of multilateral allies, and ongoing Middle East conflicts.
How Boeing Is Ramping Up 737 Production
Boeing is ramping up 737 Max production under CEO Kelly Ortberg, moving from 42 to 47 planes per month with a long-term goal of 63. After years of crises including two fatal crashes and a door plug blowout, Boeing has shifted its culture to prioritize quality over speed. The FAA is capping production rates to ensure key quality metrics are being met before further increases.
Why More Americans Are Unemployed For Longer
Over 1.8 million Americans were classified as long-term unemployed in 2026, a 55% rise from 2023, driven by a low-hire, low-fire environment shaped by high interest rates and AI adoption. The video explores the personal, societal, and economic costs of prolonged joblessness, including wage scarring, mental health deterioration, and suppressed GDP growth. First-hand accounts from unemployed workers illustrate the emotional toll of mass ghosting, rejection, and stalled job searches.
Why You Shouldn’t Worry About Ebola At The World Cup And What To Watch For Instead
A video transcript analyzing health risks at the 2026 FIFA World Cup, arguing that Ebola and hantavirus pose low threats due to robust public health infrastructure. However, officials are more concerned about measles, COVID, influenza, STDs, dengue, foodborne illness, and heat-related conditions. Health agencies have ramped up surveillance and data-sharing protocols in preparation.
How Kalshi and Polymarket are trying to copy the crypto playbook
Prediction market platforms Polymarket and Kalshi are expanding into perpetual futures contracts, a high-risk derivative product that has become a dominant force in crypto trading. This move puts them in potential competition with established crypto exchanges like Coinbase, Robinhood, and Kraken. One analyst characterizes this expansion as a defensive strategic response rather than an offensive one.
How the Iran war is disrupting the global supply chain
Gentel, a Pennsylvania-based medical supply company with ~$270M in revenue, is experiencing significant cost pressures due to the Iran war's disruption of the Strait of Hormuz. Raw material costs have surged up to 30%, with a specific dressing rising from 35 cents to 50 cents to produce. The company sources materials from 18 countries and warns further price increases are expected.
Why Trump Is Pushing Psychedelics To Treat Mental Illness
The Trump administration signed an executive order on April 18th to fast-track FDA review of psychedelic drugs for mental health treatment, issuing priority vouchers to three companies. While veterans and advocates praise the potential of treatments like MDMA and psilocybin for PTSD and depression, scientists warn that rushing the approval process could compromise research rigor. The move marks a sharp reversal from Trump's first-term drug stance, with some suggesting it may be politically motivated.
Air Taxis, Gen Z Moviegoers And Asian Cultural Boom | In Other News
CNBC's 'In Other News' covers four emerging trends: the slow and legally contentious path to certified electric air taxis, the surprising resurgence of movie-going driven by Gen Z, the explosive mainstreaming of Asian foods in American grocery stores, and the growing global popularity of South Asian music fueled by streaming and label investment.
How Trump’s Taxpayer-Funded $1.8 Billion ‘Anti-Weaponization’ Fund Works
The DOJ established a $1.776 billion 'Anti-Weaponization Fund' as part of a settlement with Trump, his sons, and the Trump Organization, who had sued the IRS over leaked tax returns. The fund, sourced from taxpayer money via the Judgment Fund, will compensate those claiming government 'weaponization,' with critics calling it a slush fund with minimal oversight. The deal has sparked bipartisan backlash, lawsuits, and constitutional concerns about Congress being bypassed on taxpayer spending.
The problem with AI demand
The AI industry is facing a broken demand signal, where token usage is being inflated by unsustainable practices like employee leaderboard gaming, runaway agent costs, and flat-rate pricing models that don't reflect real compute costs. Anthropic is the only major AI lab visibly adjusting its pricing model to reflect actual usage economics. This raises serious questions about whether the massive AI infrastructure buildout is sized for real, sustainable demand.